822 studies found for:    tuberculosis
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
Condition: Tuberculosis
Interventions: Biological: 1μg/ml ESAT6-CFP10 and tuberculin purified protein derivative;   Biological: 5μg/ml ESAT6-CFP10 and tuberculin purified protein derivative;   Biological: 10μg/ml ESAT6-CFP10 and tuberculin purified protein derivative;   Biological: 20μg/ml ESAT6-CFP10 and tuberculin purified protein derivative;   Biological: 1μg/ml ESAT6-CFP10 and placebo;   Biological: 5μg/ml ESAT6-CFP10 and placebo;   Biological: 10μg/ml ESAT6-CFP10 and placebo;   Biological: 20μg/ml ESAT6-CFP10 and placebo
2 Completed Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers
Condition: Tuberculosis
Intervention: Procedure: Quantiferon Gold
3 Completed The Effectiveness of Health Facility-based and Community-based Care for Tuberculosis
Conditions: Tuberculosis, Pulmonary;   Quality of Health Care;   Community Health Care;   Volunteer Health Workers;   Tuberculosis Treatment Effectiveness
Interventions: Other: Health workers TB care group;   Other: Community health workers TB care group;   Other: Self-administered treatment group
4 Completed Multi-Drug Resistant Tuberculosis in Korea
Condition: Tuberculosis
Intervention:
5 Recruiting The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Condition: Tuberculosis, Spinal
Interventions: Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide
6 Recruiting Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Procedure: Diagnostic techniques in pulmonary tuberculosis
7 Unknown  Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis
Conditions: Tuberculosis;   Tuberculosis, Pulmonary;   Tuberculosis, Miliary
Interventions: Device: Alere "Determine" lateral-flow urine lipoarabinomannan assay;   Device: Alere "Clearview" ELISA urine LAM assay
8 Unknown  Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa
Conditions: Tuberculosis;   Tuberculosis, Pulmonary;   Tuberculosis, Miliary
Interventions: Device: Alere "Determine" lateral-flow urine lipoarabinomannan assay;   Device: Alere "Clearview" ELISA urine LAM assay;   Device: Cepheid Xpert MTB/Rif assay
9 Unknown  Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
Condition: Latent Tuberculosis Infection
Intervention: Drug: 4-month rifampin vs. 9-month isoniazid
10 Recruiting Development of a Score for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease
Conditions: Crohn's Disease;   Intestinal Tuberculosis
Intervention:
11 Unknown  Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
Conditions: Latent Tuberculosis Infection;   Tuberculosis Disease
Intervention:
12 Completed Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients
Condition: Tuberculosis
Intervention: Biological: Intra-dermal administration of Mycobacterium w
13 Recruiting Training Protocol on the Natural History of Tuberculosis
Condition: Tuberculosis
Intervention:
14 Unknown  Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease
Conditions: Intestinal Tuberculosis;   Pulmonary Tuberculosis;   Crohn's Disease
Intervention:
15 Completed Siemens VOC TB Pilot Study
Condition: Tuberculosis
Intervention:
16 Active, not recruiting QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
Condition: Latent Tuberculosis Infection
Interventions: Drug: Preventive treatment with Isoniazid.;   Drug: Preventive treatment with Isoniazid
17 Completed Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Interventions: Drug: Qinbudan;   Drug: Qinbudan Placebo
18 Completed Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Comparator vaccine with recombinant Mycobacterium tuberculosis antigen and adjuvant system;   Biological: Comparator vaccine with recombinant Mycobacterium tuberculosis antigen and physiological saline;   Biological: Control vaccine with the adjuvant system.
19 Recruiting Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Conditions: Tuberculosis;   Tuberculosis, Pulmonary;   Early Gastric Cancer
Intervention: Drug: standard first line anti-TB drugs
20 Active, not recruiting Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
Conditions: HIV Infection;   Tuberculosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years